Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Vancomycin & Clostridioides difficile infection (CDI) (recurrent), vancomycin is FDA‑ and EMA‑approved for Clostridioides difficile infection (CDI) (via oral formulation). It does not have a specific FDA or EMA approval labeled “Clostridioides difficile infection (CDI) (recurrent)”; its role in recurrent CDI is based on guidelines and clinical practice, not a distinct regulatory indication.
Jai…